2.54
-0.08(-3.05%)
Currency In USD
| Previous Close | 2.62 |
| Open | 2.63 |
| Day High | 2.68 |
| Day Low | 2.53 |
| 52-Week High | 4.87 |
| 52-Week Low | 2.12 |
| Volume | 9.16M |
| Average Volume | 6.97M |
| Market Cap | 1.31B |
| PE | -23.09 |
| EPS | -0.11 |
| Moving Average 50 Days | 2.54 |
| Moving Average 200 Days | 2.93 |
| Change | -0.08 |
If you invested $1000 in Clover Health Investments, Corp. (CLOV) since IPO date, it would be worth $249.02 as of January 19, 2026 at a share price of $2.54. Whereas If you bought $1000 worth of Clover Health Investments, Corp. (CLOV) shares 5 years ago, it would be worth $184.73 as of January 19, 2026 at a share price of $2.54.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026
GlobeNewswire Inc.
Jan 14, 2026 1:30 PM GMT
Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026.Disciplined, core-market growth, strong returning member retention, and improving cohort ec
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
GlobeNewswire Inc.
Jan 12, 2026 1:30 PM GMT
Counterpart continues to demonstrate that unified data and real-time insights, delivered directly into the clinician’s workflow, drive measurable clinical and financial outcomesSAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, In
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
GlobeNewswire Inc.
Dec 16, 2025 9:05 PM GMT
WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the J.P. Morgan 2026 Hea